OnKure Therapeutics, Inc. Class A Common Stock (OKUR) Stock Price

OKURStock
$3.85+37.46%52W
Market Cap$155.91M
P/E
PEG Ratio
Div yield
Beta0.10

OKUR Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)45.61%
Price vs S&P 500 (4W)-4.57%
VGM Score62.31

OKUR Earnings Surprise History

Q2 25-1.14est. -1.25
Q3 25-1.09est. -1.20
Q4 25-0.99est. -1.15
Q1 26-1.11est. -0.74
Q2 26-0.31est. -0.54

OKUR Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.25
4.17
4.17
4.17

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
OKUROnKure Therapeutics, Inc. Class A Common Stock
B$3.85
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About OnKure Therapeutics, Inc. Class A Common Stock

OnKure Therapeutics is a clinical-stage biopharmaceutical company developing precision cancer medicines that target biologically validated disease drivers in underserved indications. The company focuses on oncology areas with limited existing treatment options.